Announcements Trials
Browse Landscape

Phase

Phase 2 34Phase 1 20Phase NA 18Phase 1/2 13Phase 3 9Phase EARLY_PHASE1 4Phase 4 2Phase 2/3 1

Status

Recruiting 25Not yet recruiting 11Active not recruiting 10Completed 8Terminated 2Enrolling by invitation 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Head & Neck 1

Conditions

Parathyroid Diseases 1Multiple Myeloma 1Adenoma 1

Interventions

ixazomib 1Lenalidomide 1Indocyanine Green 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Terminated × 30 days × Clear all
NCT06169735 2026-05-06

Does Fluorescence With or Without Indocyanine Green Improve Parathyroid Identification and Preservation

University of Alabama at Birmingham

Phase 4 Terminated
417 enrolled
Head & Neck

Adenoma, Parathyroid Diseases

NCT03173092 2026-05-04

A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

Takeda

Phase 4 Terminated
141 enrolled
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡